EVENT POSTPONEMENT: The health of our colleagues, visitors and wider network is our priority; therefore in light of the current global pandemic and the importance of social distancing we have taken the decision to postpone the Babraham Investor Conference, which was due to take place on the 20th May this year. We hope to set a new date for later in 2020 and will provide updates when we know more.
In the meantime we will be refunding the registration fee of all those investors that have already registered. Thank you for your understanding.
To whet your appetite for the point at which we are able to announce a new date, read our highlights from last year's event here!
Our programme features a rich array of company presentations and networking opportunities. During the course of the day you can expect:
**UPDATE** We regret that BIC 2020 has been postponed due to the COVID-19 pandemic. We hope to set a new date for later in 2020 and will update this page once we have more news on this. Thank you for your understanding.
We are delighted to announce Gerald Chan as our keynote speaker at BIC this year. A scientist and venture capitalist, Gerald has participated in the start-up of over two dozen biotechnology companies including Biovex, DNATrix, Stealth Biotherapeutics and Cognoa. Gerald chairs the Innovation Advisory Committee of the Wellcome Trust in London and the Overseers’ Committee of Morningside College, Chinese University of Hong Kong, in addition to sitting on a number of boards and committees in the US and UK.
We regret that BIC 2020 has been postponed due to the COVID-19 pandemic. We hope to set a new date for later in 2020 and will re-open investor registrations once we have more news on this. Thank you for your understanding.
**UPDATE** We regret that BIC 2020 has been postponed due to the COVID-19 pandemic. We hope to set a new date for later in 2020 and will re-open applications to present once we have more news on this. Thank you for your understanding.
Typically, presenting companies will be seeking funding of between £250K to £20M. Presenting slots of 15 minutes each (including Q&A) are available. There is also ample time for networking in-between sessions and the opportunity to have an exhibition stand. There is no charge to apply, however, we do request a fee of £100+VAT from each company successful in securing a slot to present.
Handelsbanken is a full-service bank with a decentralised way of working, a strong local presence due to a nationwide network of over 200 branches and a long-term approach to customer relations.
(+44) 1223 496 000
Babraham Bioscience Technologies Ltd
Babraham Research Campus
CB22 3AT, United Kingdom
01223 813 557